The clinical presentation of HE varies widely by disease severity and neurocognitive impairment. In MHE, patients might not have obvious clinical changes but instead may have abnormal psychometric ...

Background and Aim: Development of overt hepatic encephalopathy (HE) is associated with poor prognosis in patients with cirrhosis. Lactulose is used for the treatment of HE. There is no study on ...

Considering taking supplements to treat hepatic encephalopathy? Below is a list of common natural remedies used to treat or reduce the symptoms of hepatic encephalopathy. Follow the links to read ...

Discover top medications for 'treating Hepatic Encephalopathy'? This page compiles essential information on generic and brand-name drugs specifically used for Hepatic Encephalopathy treatment.Here ...

Background and Aims: Acute variceal bleed (AVB) is an important precipitating factor for development of hepatic encephalopathy (HE). However, there is paucity of data on the role of lactulose for ...

To resolve the question of a hepatic component in the metabolic encephalopathy, a provocative load of ammonium chloride was administered by mouth, and after 12 gm. had been given over a twenty ...

Background and aims The performance of neurodegenerative biomarkers-neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), tau, and ubiquitin carboxy-terminal hydrolase L1 (UCHL1)-in ...